• Info
  • Insider Ownership

Insider Trading & Ownership of ERROL B. DESOUZA

Location
Paramus, NJ
Summary
The estimated net worth of ERROL B. DESOUZA is at least $5,025,168 dollars as of 12 Jun 2025. ERROL B. DESOUZA is the Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $4.83M. ERROL B. DESOUZA is the Director of Cyclerion Therapeutics, Inc. and owns shares of Cyclerion Therapeutics, Inc. (CYCN) stock worth about $101.8K. ERROL B. DESOUZA is the Director of Alector, Inc. and owns shares of Alector, Inc. (ALEC) stock worth about $81.1K. ERROL B. DESOUZA is the Director of CATALYST BIOSCIENCES, INC. and owns shares of GYRE THERAPEUTICS, INC. (GYRE) stock worth about $14K.
Signature
/s/ Marc Grasso, by power of attorney
All Insider Reports
All Insider Reports

Notify me when ERROL B. DESOUZA files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of ERROL B. DESOUZA

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RPRX Royalty Pharma plc Director $4,828,170 13 May 2025
CYCN Cyclerion Therapeutics, Inc. Director $101,850 30 Nov 2023
ALEC Alector, Inc. Director $81,142 11 Jun 2025
GYRE CATALYST BIOSCIENCES, INC. Director $14,006 01 Oct 2021

Insider Transactions Reported by ERROL B. DESOUZA:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.